Related Experiment Video

Updated: Aug 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

[New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia]

Noriko Usui

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |May 24, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
    06:51

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

    Published on: December 17, 2019

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
    06:51

    Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

    Published on: December 17, 2019

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

    International journal of hematology·2023

    Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

    International journal of hematology·2023

    THE SURFACE EVENTS AT FERTILIZATION OF THE SEA URCHIN EGG I. EVENTS ON THE SURFACE OF THE VITELLINE COAT

    Development, growth & differentiation·2023

    CHANGES IN CELL SURFACE MORPHOLOGY DURING DIFFERENTIATION OF MICROMERE- AND MESOMERE-DERIVED CELLS OF THE SEA URCHIN EMBRYO.

    Development, growth & differentiation·2023

    Regional Response to Cytochalasin B of the Equatorial Cell Cortex in Sea-Urchin Eggs during the First Mitosis: (surface architecture/cortical microfilaments/cytochalasin B/sea-urchin egg/first mitosis).

    Development, growth & differentiation·2023

    MAGNESIUM ION-REQUIRING STEP IN FERTILIZATION OF SEA URCHINS.

    Development, growth & differentiation·2023

    [Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Complement-coagulation crosstalk in immunothrombosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    Switching apo- and holo-IscR control of LcrF alters how iron and oxygen regulate Yersinia virulence factors.

    Infection and immunity·2026

    Time- and Temperature-Dependent Response of Acquired FV Inhibitors: Implications for Laboratory Diagnosis and Clinical Management.

    Journal of clinical laboratory analysis·2026

    Photocatalytic Construction of Multivalent Peptide-Human Serum Albumin (HSA) Conjugates Capable of Effectively Attenuating Phagocytosis.

    ACS applied materials & interfaces·2026

    Indole hybrids as promising anti-hepatocellular carcinoma agents: a comprehensive review of recent advances and therapeutic prospects.

    Future medicinal chemistry·2026

    The Diagnostic Mirage: Xanthogranulomatous Cholecystitis and the Illusion of Gallbladder Carcinoma.

    Cureus·2026

    The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups.

    HemaSphere·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us